The US Food and Drug Administration recently began hearings into pharmaceutical marketing – and specifically online pharmaceutical marketing. And it seems the marketers are happy to take some guidance.
The news this week of veteran news heads Mark Jennings and Tim Murphy launching a news service was widely celebrated across journalism circles, with many applauding the arrival of a publication dedicated to, as Murphy said, focusing on quality and “doing the news”. But was that excitement a bit pre-emptive? And – the question of the ages – how is it going to pay for it all?